Nitric oxide availability as a marker of oxidative stress

Advanced Protocols in Oxidative Stress III

Volumn , Issue , 2014, Pages 63-71

  Pierini, Dan ^a   Bryan, Nathan S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

HPLC chemiluminescence; Nitric oxide; Organ bath myography; Oxidative stress; Reactive oxygen species

Indexed keywords

EID: 84921841162     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-1441-8_5     Document Type: Chapter

References (20)

1. Ghosh M, Wang HD, McNeill JR (2004) Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats. Br J Pharmacol 141(4):562-573.
2. Bryan NS et al (2004) Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci U S A 101(12):4308-4313.
3. Gerhard M et al (1996) Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 27(4):849-853.
4. Taddei S et al (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38(2):274-279.
5. Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 Suppl 1):III27-III32.
6. Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101(16):1899-1906.
7. Halcox JP et al (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106(6):653-658.
8. Bugiardini R et al (2004) Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 109(21):2518-2523.
9. Lerman A, Zeiher AM (2005) Endothelial function: cardiac events. Circulation 111(3):363-368.
10. Forstermann U (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch 459(6):923-939.
11. Popolo A et al (2013) Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radic Res 47(5):346-356.
12. Gryglewski RJ, Palmer RM, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320(6061):454-456.
13. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271(5 Pt 1):C1424-C1437.
14. Beckman JS et al (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87(4):1620-1624.
15. Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9(5):836-844.
16. Hamilton CA et al (2001) Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37(2 Pt 2):529-534.
17. van der Loo B et al (2000) Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192(12):1731-1744.
18. Bryan NS et al (2005) Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 1(5):290-297.
19. Marley R et al (2001) Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide. Free Radic Biol Med 31(5):688-696.
20. Rodriguez J et al (2003) Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci U S A 100:336-341.